Schizophrenia: What’s arc got to do with it?

Frontiers in Behavioral Neuroscience

Volumn 11, Issue , 2017, Pages

  Managò, Francesca ^a   Papaleo, Francesco ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Arg3.1; Behavior; Dopamine; Glutamate; Immediate early gene; Mice; RDoC

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; DOPAMINE; GLUTAMIC ACID; NEUROLEPTIC AGENT;

ACTIVITY REGULATED CYTOSKELETAL ASSOCIATED GENE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONCEPTUAL FRAMEWORK; COPY NUMBER VARIATION; DNA MODIFICATION; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; GENE STRUCTURE; GLUTAMATERGIC SYSTEM; HUMAN; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN PROTEIN INTERACTION; QUALITY OF LIFE; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL PSYCHOLOGY;

EID: 85031816860     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2017.00181     Document Type: Review

References (123)

1. Alberi, L., Liu, S., Wang, Y., Badie, R., Smith-Hicks, C., Wu, J., et al. (2011). Activity-induced Notch signaling in neurons requires Arc/Arg3.1 and is essential for synaptic plasticity in hippocampal networks. Neuron 69, 437-444. doi: 10.1016/j.neuron.2011.01.004
2. Aleman, A., Hijman, R., de Haan, E. H., and Kahn, R. S. (1999). Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry 156, 1358-1366. doi: 10.1176/ajp.156.9.1358
3. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
4. Andiné, P., Widermark, N., Axelsson, R., Nyberg, G., Olofsson, U., Mårtensson, E., et al. (1999). Characterization of MK-801-induced behavior as a putative rat model of psychosis. J. Pharmacol. Exp. Ther. 290, 1393-1408.
5. Arguello, P. A., and Gogos, J. A. (2006). Modeling madness in mice: one piece at a time. Neuron 52, 179-196. doi: 10.1016/j.neuron.2006. 09.023
6. Banerjee, P. S., Aston, J., Khundakar, A. A., and Zetterstrom, T. S. (2009). Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain. Eur. J. Neurosci. 29, 465-476. doi: 10.1111/j.1460-9568.2008. 06601.x
7. Barker, G. R. I., Bird, F., Alexander, V., and Warburton, E. C. (2007). Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J. Neurosci. 27, 2948-2957. doi: 10.1523/jneurosci.5289-06.2007
8. Beckstead, R. M., Domesick, V. B., and Nauta, W. J. (1979). Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191-217. doi: 10.1016/0006-8993(79)91001-1
9. Bi, R., Kong, L. L., Xu, M., Li, G. D., Zhang, D. F., Alzheimer’s Disease Neuroimaging Initiative, et al. (2017). The arc gene confers genetic susceptibility to Alzheimer’s disease in Han Chinese. Mol. Neurobiol. doi: 10.1007/s12035-017-0397-6
10. Biever, A., Boubaker-Vitre, J., Cutando, L., Gracia-Rubio, I., Costa-Mattioli, M., Puighermanal, E., et al. (2017). Repeated exposure to D-Amphetamine decreases global protein synthesis and regulates the translation of a subset of mRNAs in the striatum. Front. Mol. Neurosci. 9:165. doi: 10.3389/fnmol.2016. 00165
11. Billeke, P., and Aboitiz, F. (2013). Social cognition in schizophrenia: from social stimuli processing to social engagement. Front. Psychiatry 4:4. doi: 10.3389/fpsyt.2013.00004
12. Bloomer, W. A., VanDongen, H. M., and VanDongen, A. M. (2008). Arc/Arg3.1 translation is controlled by convergent N-methyl-D-aspartate and Gs-coupled receptor signaling pathways. J. Biol. Chem. 283, 582-592. doi: 10.1074/jbc.m702451200
13. Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 16, 551-563. doi: 10.1038/ nrn3992
14. Braff, D. L., and Geyer, M. A. (1990). Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 47, 181-188. doi: 10.1001/archpsyc.1990.01810140081011
15. Bramham, C. R., Alme, M. N., Bittins, M., Kuipers, S. D., Nair, R. R., Pai, B., et al. (2010). The arc of synaptic memory. Exp. Brain Res. 200, 125-140. doi: 10.1007/s00221-009-1959-2
16. Bugarski-Kirola, D., Iwata, N., Sameljak, S., Reid, C., Blaettler, T., Millar, L., et al. (2016). Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme. Lancet Psychiatry 3, 1115-1128. doi: 10.1016/s2215-0366(16)30344-3
17. Cadenhead, K. S., Geyer, M. A., and Braff, D. L. (1993). Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am. J. Psychiatry 150, 1862-1867. doi: 10.1176/ajp.150. 12.1862
18. Cadenhead, K. S., Swerdlow, N. R., Shafer, K. M., Diaz, M., and Braff, D. L. (2000). Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am. J. Psychiatry 157, 1660-1668. doi: 10.1176/appi.ajp.157.10.1660
19. Cao, C., Rioult-Pedotti, M. S., Migani, P., Yu, C. J., Tiwari, R., Parang, K., et al. (2013). Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol. 11:e1001478. doi: 10.1371/journal.pbio.1001478
20. Cardno, A. G., and Gottesman, I. I. (2000). Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 97, 12-17. doi: 10.1002/(sici)1096-8628(200021) 97:1<12::aid-ajmg3>3.3.co;2-l
21. Chen, Y., Bang, S., McMullen, M. F., Kazi, H., Talbot, K., Ho, M. X., et al. (2017). Neuronal activity-induced sterol regulatory element binding protein-1 (SREBP1) is disrupted in dysbindin-null mice-potential link to cognitive impairment in schizophrenia. Mol. Neurobiol. 54, 1699-1709. doi: 10.1007/s12035-016-9773-x
22. Chia, C., and Otto, T. (2013). Hippocampal Arc (Arg3.1) expression is induced by memory recall and required for memory reconsolidation in trace fear conditioning. Neurobiol. Learn. Mem. 106, 48-55. doi: 10.1016/j.nlm. 2013.06.021
23. Chowdhury, S., Shepherd, J. D., Okuno, H., Lyford, G., Petralia, R. S., Plath, N., et al. (2006). Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52, 445-459. doi: 10.1016/j.neuron.2006. 08.033
24. Contarino, A., Kitchener, P., Vallée, M., Papaleo, F., and Piazza, P. V. (2017). CRF1 receptor-deficiency increases cocaine reward. Neuropharmacology 117, 41-48. doi: 10.1016/j.neuropharm.2017.01.024
25. Coyle, J. T. (2006). Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 26, 363-382. doi: 10.1007/s10571-006-9062-8
26. Czerniawski, J., Ree, F., Chia, C., Ramamoorthi, K., Kumata, Y., and Otto, T. A. (2011). The importance of having Arc: expression of the immediate-early gene Arc is required for hippocampus-dependent fear conditioning and blocked by NMDA receptor antagonism. J. Neurosci. 31, 11200-11207. doi: 10.1523/jneurosci.2211-11.2011
27. Dreher, J.-C., Banquet, J.-P., Allilaire, J. F., Paillère-Martinot, M.-L., Dubois, B., and Burnod, Y. (2001). Temporal order and spatial memory in schizophrenia: a parametric study. Schizophr. Res. 51, 137-147. doi: 10.1016/s0920-9964(00)00151-1
28. Ebert, D. H., and Greenberg, M. E. (2013). Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493, 327-337. doi: 10.1038/nature11860
29. Fett, A. K., Viechtbauer, W., Dominguez, M. D., Penn, D. L., van Os, J., and Krabbendam, L. (2011). The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci. Biobehav. Rev. 35, 573-588. doi: 10.1016/j.neubiorev.2010.07.001
30. Folley, B. S., Astur, R., Jagannathan, K., Calhoun, V. D., and Pearlson, G. D. (2010). Anomalous neural circuit function in schizophrenia during a virtual Morris water task. Neuroimage 49, 3373-3384. doi: 10.1016/j.neuroimage.2009.11.034
31. Frohlich, J., and Van Horn, J. D. (2014). Reviewing the ketamine model for schizophrenia. J. Psychopharmacol. 28, 287-302. doi: 10.1177/0269881113512909
32. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184. doi: 10.1038/nature12929
33. Fumagalli, F., Franchi, C., Caffino, L., Racagni, G., Riva, M. A., and Cervo, L. (2009). Single session of cocaine intravenous self-administration shapes goal-oriented behaviours and up-regulates Arc mRNA levels in rat medial prefrontal cortex. Int. J. Neuropsychopharmacol. 12, 423-429. doi: 10.1017/s1461145708009681
34. Gao, M., Sossa, K., Song, L., Errington, L., Cummings, L., Hwang, H., et al. (2010). A specific requirement of Arc/Arg3.1 for visual experience-induced homeostatic synaptic plasticity in mouse primary visual cortex. J. Neurosci. 30, 7168-7178. doi: 10.1523/jneurosci.1067-10.2010
35. Garber, K. B., Visootsak, J., and Warren, S. T. (2008). Fragile X syndrome. Eur. J. Hum. Genet. 16, 666-672. doi: 10.1038/ejhg.2008.61
36. Gard, D. E., Fisher, M., Garrett, C., Genevsky, A., and Vinogradov, S. (2009). Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia. Schizophr. Res. 115, 74-81. doi: 10.1016/j. schres.2009.08.015
37. Goes, F. S., Pirooznia, M., Parla, J. S., Kramer, M., Ghiban, E., Mavruk, S., et al. (2016). Exome sequencing of familial bipolar disorder. JAMA Psychiatry 73, 590-597. doi: 10.1001/jamapsychiatry.2016.0251
38. Goldberg, T. E., Weinberger, D. R., Pliskin, N. H., Berman, K. F., and Podd, M. H. (1989). Recall memory deficit in schizophrenia. A possible manifestation of prefrontal dysfunction. Schizophr. Res. 2, 251-257. doi: 10.1016/0920-9964(89)90001-7
39. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321-330. doi: 10.1176/ajp. 153.3.321
40. Green, M. F., Horan, W. P., and Lee, J. (2015). Social cognition in schizophrenia. Nat. Rev. Neurosci. 16, 620-631. doi: 10.1038/nrn4005
41. Green, M. F., and Nuechterlein, K. H. (1999). Should schizophrenia be treated as a neurocognitive disorder? Schizophr. Bull. 25, 309-319. doi: 10.1093/oxfordjournals.schbul.a033380
42. Greer, P. L., Hanayama, R., Bloodgood, B. L., Mardinly, A. R., Lipton, D. M., Flavell, S. W., et al. (2010). The angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704-716. doi: 10.1016/j. cell.2010.01.026
43. Guillozet-Bongaarts, A. L., Hyde, T. M., Dalley, R. A., Hawrylycz, M. J., Henry, A., Hof, P. R., et al. (2014). Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 19, 478-485. doi: 10.1038/mp.2013.30
44. Guzowski, J. F., Lyford, G. L., Stevenson, G. D., Houston, F. P., McGaugh, J. L., Worley, P. F., et al. (2000). Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. 20, 3993-4001.
45. Halberstadt, A. L. (1995). The phencyclidine-glutamate model of schizophrenia. Clin. Neuropharmacol. 18, 237-249. doi: 10.1097/00002826-199506000-00004
46. Harvey, P. D., Koren, D., Reichenberg, A., and Bowie, C. R. (2006). Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr. Bull. 32, 250-258. doi: 10.1093/schbul/sbj011
47. Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., et al. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychoticinduced side effects. World J. Biol. Psychiatry 14, 2-44. doi: 10.3109/15622975. 2012.739708
48. Hu, J., Sathanoori, M., Kochmar, S., Azage, M., Mann, S., Madan-Khetarpal, S., et al. (2015). A novel maternally inherited 8q24.3 and a rare paternally inherited 14q23.3 CNVs in a family with neurodevelopmental disorders. Am. J. Med. Genet. A 167A, 1921-1926. doi: 10.1002/ajmg. a.37110
49. Huentelman, M. J., Muppana, L., Corneveaux, J. J., Dinu, V., Pruzin, J. J., Reiman, R., et al. (2015). Association of SNPs in EGR3 and ARC with schizophrenia supports a biological pathway for schizophrenia risk. PLoS One 10:e0135076. doi: 10.1371/journal.pone.0135076
50. Iwata, Y., Nakajima, S., Suzuki, T., Keefe, R. S., Plitman, E., Chung, J. K., et al. (2015). Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials. Mol. Psychiatry 20, 1151-1160. doi: 10.1038/mp. 2015.68
51. Jakkamsetti, V., Tsai, N. P., Gross, C., Molinaro, G., Collins, K. A., Nicoletti, F., et al. (2013). Experience-induced Arc/Arg3.1 primes CA1 pyramidal neurons for metabotropic glutamate receptor-dependent long-term synaptic depression. Neuron 80, 72-79. doi: 10.1016/j.neuron.2013.07.020
52. Kalsbeek, A., Voorn, P., Buijs, R. M., Pool, C. W., and Uylings, H. B. (1988). Development of the dopaminergic innervation in the prefrontal cortex of the rat. J. Comp. Neurol. 269, 58-72. doi: 10.1002/cne. 902690105
53. Kantrowitz, J. T., and Javitt, D. C. (2010). N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?. Brain Res. Bull. 83, 108-121. doi: 10.1016/j.brainresbull.2010. 04.006
54. Kozorovitskiy, Y., Saunders, A., Johnson, C. A., Lowell, B. B., and Sabatini, B. L. (2012). Recurrent network activity drives striatal synaptogenesis. Nature 485, 646-650. doi: 10.1038/nature11052
55. Kumar, V., Fahey, P. G., Jong, Y. J., Ramanan, N., and O’Malley, K. L. (2012). Activation of intracellular metabotropic glutamate receptor 5 in striatal neurons leads to up-regulation of genes associated with sustained synaptic transmission including Arc/Arg3.1 protein. J. Biol. Chem. 287, 5412-5425. doi: 10.1074/jbc.M111.301366
56. Lambert, J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452-1458. doi: 10.1038/ng.2802
57. Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., and Innis, R. (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 46, 56-72. doi: 10.1016/s0006-3223(99)00067-0
58. Lewis, D. A., and Gonzalez-Burgos, G. (2006). Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 12, 1016-1022. doi: 10.1038/nm1478
59. Lewis, D. A., and Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409-432. doi: 10.1146/annurev. neuro.25.112701.142754
60. Lewis, B. L., and O’Donnell, P. (2000). Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential ‘up’ states in pyramidal neurons via D(1) dopamine receptors. Cereb. Cortex 10, 1168-1175. doi: 10.1093/cercor/10.12.1168
61. Li, Y., Pehrson, A. L., Waller, J. A., Dale, E., Sanchez, C., and Gulinello, M. (2015). A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)’s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression. Front. Neurosci. 9:279. doi: 10.3389/fnins.2015.00279
62. Link, W., Konietzko, U., Kauselmann, G., Krug, M., Schwanke, B., Frey, U., et al. (1995). Somatodendritic expression of an immediate early gene is regulated by synaptic activity. Proc. Natl. Acad. Sci. U S A 92, 5734-5738. doi: 10.1073/pnas. 92.12.5734
63. Lyford, G. L., Yamagata, K., Kaufmann, W. E., Barnes, C. A., Sanders, L. K., Copeland, N. G., et al. (1995). Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433-445. doi: 10.1016/0896-6273(95) 90299-6
64. Malkki, H. A., Mertens, P. E., Lankelma, J. V., Vinck, M., van Schalkwijk, F. J., van Mourik-Donga, L. B., et al. (2016). Effects of Arc/Arg3.1 gene deletion on rhythmic synchronization of hippocampal CA1 neurons during locomotor activity and sleep. Neurobiol. Learn. Mem. 131, 155-165. doi: 10.1016/j.nlm. 2016.03.021
65. Managò, F., Mereu, M., Mastwal, S., Mastrogiacomo, R., Scheggia, D., Emanuele, M., et al. (2016). Genetic disruption of Arc/Arg3.1 in mice causes alterations in dopamine and neurobehavioral phenotypes related to schizophrenia. Cell Rep. 16, 2116-2128. doi: 10.1016/j.celrep.2016.07.044
66. Manitt, C., Mimee, A., Eng, C., Pokinko, M., Stroh, T., Cooper, H. M., et al. (2011). The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J. Neurosci. 31, 8381-8394. doi: 10.1523/JNEUROSCI.0606-11.2011
67. Marshall, C. R., Howrigan, D. P., Merico, D., Thiruvahindrapuram, B., Wu, W., and Greer, D. S. (2017). Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat. Genet. 49, 27-35. doi: 10.1038/ng.3725
68. Mastwal, S., Ye, Y., Ren, M., Jimenez, D. V., Martinowich, K., Gerfen, C. R., et al. (2014). Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescence. J. Neurosci. 34, 9484-9496. doi: 10.1523/JNEUROSCI. 1114-14.2014
69. Matsuo, N., Yamasaki, N., Ohira, K., Takao, K., Toyama, K., Eguchi, M., et al. (2009). Neural activity changes underlying the working memory deficit in a-CaMKII heterozygous knockout mice. Front. Behav. Neurosci. 3:20. doi: 10.3389/neuro.08.020.2009
70. McCarthy, S. E., Gillis, J., Kramer, M., Lihm, J., Yoon, S., Berstein, Y., et al. (2014). De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol. Psychiatry 19, 652-658. doi: 10.1038/mp.2014.29
71. McIntyre, C. K., Miyashita, T., Setlow, B., Marjon, K. D., Steward, O., Guzowski, J. F., et al. (2005). Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus. Proc. Natl. Acad. Sci. U S A 102, 10718-10723. doi: 10.1073/pnas. 0504436102
72. Mereu, M., Contarini, G., Buonaguro, E. F., Latte, G., Managò, F., Iasevoli, F., et al. (2017). Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder. Neuropharmacology 121, 179-194. doi: 10.1016/j.neuropharm.2017.04.037
73. Messaoudi, E., Kanhema, T., Soulé, J., Tiron, A., Dagyte, G., da Silva, B., et al. (2007). Sustained Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization in the dentate gyrus in vivo. J. Neurosci. 27, 10445-10455. doi: 10.1523/JNEUROSCI. 2883-07.2007
74. Meyer-Lindenberg, A., and Weinberger, D. R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7, 818-827. doi: 10.1038/nrn1993
75. Millan, M. J., Fone, K., Steckler, T., and Horan, W. P. (2014). Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur. Neuropsychopharmacol. 24, 645-692. doi: 10.1016/j.euroneuro.2014.03.008
76. Miyamoto, S., Duncan, G. E., Marx, C. E., and Lieberman, J. A. (2005). Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 10, 79-104. doi: 10.1038/sj.mp. 4001556
77. Miyashita, T., Kubik, S., Lewandowski, G., and Guzowski, J. F. (2008). Networks of neurons, networks of genes: an integrated view of memory consolidation. Neurobiol. Learn. Mem. 89, 269-284. doi: 10.1016/j.nlm.2007.08.012
78. Moro, H., Sato, H., Ida, I., Oshima, A., Sakurai, N., Shihara, N., et al. (2007). Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamineinduced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Pharmacol. Biochem. Behav. 87, 56-64. doi: 10.1016/j. pbb.2007.03.020
79. Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., et al. (2004). Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 3, 287-302. doi: 10.1111/j.1601-1848.2004.00076.x
80. Moy, S. S., Nadler, J. J., Young, N. B., Nonneman, R. J., Segall, S. K., Andrade, G. M., et al. (2008). Social approach and repetitive behavior in eleven inbred mouse strains. Behav. Brain Res. 191, 118-129. doi: 10.1016/j.bbr.2008. 03.015
81. Mueser, K. T., and McGurk, S. R. (2004). Schizophrenia. Lancet 363, 2063-2072. doi: 10.1016/S0140-6736(04)16458-1
82. Myrum, C., Baumann, A., Bustad, H. J., Flydal, M. I., Mariaule, V., Alvira, S., et al. (2015a). Arc is a flexible modular protein capable of reversible selfoligomerization. Biochem. J. 468, 145-158. doi: 10.1042/BJ20141446
83. Myrum, C., Giddaluru, S., Jacobsen, K., Espeseth, T., Nyberg, L., Lundervold, A. J., et al. (2015b). Common variants in the ARC gene are not associated with cognitive abilities. Brain Behav. 5:e00376. doi: 10.1002/brb3.376
84. Nakayama, D., Iwata, H., Teshirogi, C., Ikegaya, Y., Matsuki, N., and Nomura, H. (2015). Long-delayed expression of the immediate early gene Arc/Arg3.1 refines neuronal circuits to perpetuate fear memory. J. Neurosci. 35, 819-830. doi: 10.1523/JNEUROSCI.2525-14.2015
85. Niere, F., Wilkerson, J. R., and Huber, K. M. (2012). Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. J. Neurosci. 32, 5924-5936. doi: 10.1523/JNEUROSCI.4650-11.2012
86. NIH/NIMH. (2017). Research Domain Criteria (RDoC). Available online at: https://www.nimh.nih.gov/research-priorities/rdoc/index.shtml
87. O’Donovan, M. C., and Owen, M. J. (2016). The implications of the shared genetics of psychiatric disorders. Nat. Med. 22, 1214-1219. doi: 10.1038/nm.4196
88. Okuno, H., Akashi, K., Ishii, Y., Yagishita-Kyo, N., Suzuki, K., Nonaka, M., et al. (2012). Inverse synaptic tagging of inactive synapses via dynamic interaction of Arc/Arg3.1 with CaMKIIb. Cell 149, 886-898. doi: 10.1016/j.cell.2012.02.062
89. Papaleo, F., Lipska, B. K., and Weinberger, D. R. (2012). Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology 62, 1204-1220. doi: 10.1016/j.neuropharm.2011.04.025
90. Park, S., Park, J. M., Kim, S., Kim, J. A., Shepherd, J. D., Smith-Hicks, C. L., et al. (2008). Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59, 70-83. doi: 10.1016/j.neuron.2008.05.023
91. Plath, N., Ohana, O., Dammermann, B., Errington, M. L., Schmitz, D., Gross, C., et al. (2006). Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52, 437-444. doi: 10.1016/j.neuron.2006.08.024
92. Ploski, J. E., Pierre, V. J., Smucny, J., Park, K., Monsey, M. S., Overeem, K. A., et al. (2008). The activity-regulated cytoskeletal-associated protein (Arc/Arg3.1) is required for memory consolidation of pavlovian fear conditioning in the lateral amygdala. J. Neurosci. 28, 12383-12395. doi: 10.1523/JNEUROSCI.1662-08.2008
93. Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., et al. (2014). A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190. doi: 10.1038/nature12975
94. Ranganath, C., Minzenberg, M. J., and Ragland, J. D. (2008). The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol. Psychiatry 64, 18-25. doi: 10.1016/j.biopsych.2008.04.011
95. Ren, M., Cao, V., Ye, Y., Manji, H. K., and Wang, K. H. (2014). Arc regulates experience-dependent persistent firing patterns in frontal cortex. J. Neurosci. 34, 6583-6595. doi: 10.1523/JNEUROSCI.0167-14.2014
96. Rial Verde, E. M., Lee-Osbourne, J., Worley, P. F., Malinow, R., and Cline, H. T. (2006). Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron 52, 461-474. doi: 10.1016/j.neuron.2006.09.031
97. Rizzo, L., Danion, J. M., van der Linden, M., and Grange, D. (1996). Patients with schizophrenia remember that an event has occurred, but not when. Br. J. Psychiatry 168, 427-431. doi: 10.1192/bjp.168.4.427
98. Salery, M., Dos Santos, M., Saint-Jour, E., Moumné, L., Pagès, C., Kappès, V., et al. (2017). Activity-regulated cytoskeleton-associated protein accumulates in the nucleus in response to cocaine and acts as a brake on chromatin remodeling and long-term behavioral alterations. Biol. Psychiatry 81, 573-584. doi: 10.1016/j. biopsych.2016.05.025
99. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427. doi: 10.1038/nature13595
100. Schwartz, B. L., Deutsch, L. H., Cohen, C., Warden, D., and Deutsch, S. I. (1991). Memory for temporal order in schizophrenia. Biol. Psychiatry 29, 329-339. doi: 10.1016/0006-3223(91)90218-b
101. Shepherd, J. D., and Bear, M. F. (2011). New views of Arc, a master regulator of synaptic plasticity. Nat. Neurosci. 14, 279-284. doi: 10.1038/nn.2708
102. Shepherd, J. D., Rumbaugh, G., Wu, J., Chowdhury, S., Plath, N., Kuhl, D., et al. (2006). Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron 52, 475-484. doi: 10.1016/j.neuron.2006.08.034
103. Simpson, E. H., Kellendonk, C., and Kandel, E. (2010). A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 65, 585-596. doi: 10.1016/j.neuron.2010.02.014
104. Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J. L., Narendran, R., Gil, R., et al. (2015). Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72, 316-324. doi: 10.1001/jamapsychiatry.2014.2414
105. Smith, S. E., Zhou, Y. D., Zhang, G., Jin, Z., Stoppel, D. C., and Anderson, M. P. (2011). Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci. Transl. Med. 3:103ra197. doi: 10.1126/scitranslmed.3002627
106. Steward, O., and Worley, P. F. (2001). Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation. Neuron 30, 227-240. doi: 10.1016/s0896-6273(01)00275-6
107. Sullivan, P. F., Kendler, K. S., and Neale, M. C. (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187-1192. doi: 10.1001/archpsyc.60.12.1187
108. Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., and Braff, D. L. (2008). Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199, 331-388. doi: 10.1007/s00213-008-1072-4
109. Takagi, S., Balu, D. T., and Coyle, J. T. (2015). Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice. Schizophr. Res. 162, 216-221. doi: 10.1016/j.schres.2014. 12.034
110. Takao, K., Kobayashi, K., Hagihara, H., Ohira, K., Shoji, H., Hattori, S., et al. (2013). Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 38, 1409-1425. doi: 10.1038/npp.2013.38
111. Tzingounis, A. V., and Nicoll, R. A. (2006). Arc/Arg3.1: linking gene expression to synaptic plasticity and memory. Neuron 52, 403-407. doi: 10.1016/j.neuron. 2006.10.016
112. van den Buuse, M. (2010). Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull. 36, 246-270. doi: 10.1093/schbul/sbp132
113. Vazdarjanova, A., Ramirez-Amaya, V., Insel, N., Plummer, T. K., Rosi, S., Chowdhury, S., et al. (2006). Spatial exploration induces ARC, a plasticityrelated immediate-early gene, only in calcium/calmodulin-dependent protein kinase II-positive principal excitatory and inhibitory neurons of the rat forebrain. J. Comp. Neurol. 498, 317-329. doi: 10.1002/cne. 21003
114. Wang, H., Ardiles, A. O., Yang, S., Tran, T., Posada-Duque, R., Valdivia, G., et al. (2016). Metabotropic glutamate receptors induce a form of LTP controlled by translation and Arc signaling in the hippocampus. J. Neurosci. 36, 1723-1729. doi: 10.1523/JNEUROSCI.0878-15.2016
115. Waung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A., and Huber, K. M. (2008). Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate. Neuron 59, 84-97. doi: 10.1016/j.neuron.2008.05.014
116. Weinstein, J. J., Chohan, M. O., Slifstein, M., Kegeles, L. S., Moore, H., and Abi-Dargham, A. (2017). Pathway-specific dopamine abnormalities in schizophrenia. Biol. Psychiatry 81, 31-42. doi: 10.1016/j.biopsych. 2016.03.2104
117. Wiedholz, L. M., Owens, W. A., Horton, R. E., Feyder, M., Karlsson, R. M., Hefner, K., et al. (2008). Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors. Mol. Psychiatry 13, 631-640. doi: 10.1038/sj.mp.4002056
118. Williams, C. A., Driscoll, D. J., and Dagli, A. I. (2010). Clinical and genetic aspects of Angelman syndrome. Genet. Med. 12, 385-395. doi: 10.1097/GIM. 0b013e3181def138
119. Winterer, G., and Weinberger, D. R. (2004). Genes, dopamine and cortical signalto-noise ratio in schizophrenia. Trends Neurosci. 27, 683-690. doi: 10.1016/j. tins.2004.08.002
120. Wu, J., Petralia, R. S., Kurushima, H., Patel, H., Jung, M. Y., Volk, L., et al. (2011). Arc/Arg3.1 regulates an endosomal pathway essential for activitydependent b-amyloid generation. Cell 147, 615-628. doi: 10.1016/j.cell. 2011.09.036
121. Ye, Y., Mastwal, S., Cao, V. Y., Ren, M., Liu, Q., Zhang, W., et al. (2016). Dopamine is required for activity-dependent amplification of Arc mRNA in developing postnatal frontal cortex. Cereb. Cortex doi: 10.1093/cercor/bhw181
122. Zhang, W., Wu, J., Ward, M. D., Yang, S., Chuang, Y. A., Xiao, M., et al. (2015). Structural basis of arc binding to synaptic proteins: implications for cognitive disease. Neuron 86, 490-500. doi: 10.1016/j.neuron. 2015.03.030
123. Zhao, H., and Nyholt, D. R. (2017). Gene-based analyses reveal novel genetic overlap and allelic heterogeneity across five major psychiatric disorders. Hum. Genet. 136, 263-274. doi: 10.1007/s00439-016-1755-6